Home

Barn sju Klargörande teva sec filings Recitera Strapats Cyklop

DEF 14A
DEF 14A

TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is Migdal Insurance &  Financial Holdings Ltd.'s 3rd Largest Position - MarketBeat
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is Migdal Insurance & Financial Holdings Ltd.'s 3rd Largest Position - MarketBeat

Teva Pharmaceutical Industries Ltd. - Investors
Teva Pharmaceutical Industries Ltd. - Investors

As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech

Teva- Pharmaceutical Industries (TEVA) | Better than Yahoo Finance |  wallmine
Teva- Pharmaceutical Industries (TEVA) | Better than Yahoo Finance | wallmine

DEF 14A
DEF 14A

Teva Pharmaceutical Industries Ltd. - Financials - SEC Filings
Teva Pharmaceutical Industries Ltd. - Financials - SEC Filings

DEF 14A
DEF 14A

Teva's Restructuring Plan (NYSE:TEVA) | Seeking Alpha
Teva's Restructuring Plan (NYSE:TEVA) | Seeking Alpha

Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug  Development and Chronic Disease Management with Watson
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with Watson

Teva Pharmaceutical Industries Ltd. - Financials - SEC Filings
Teva Pharmaceutical Industries Ltd. - Financials - SEC Filings

Teva won't say whether R&D cuts include layoffs; Cipla inks deal for  Iranian plant; | Fierce Pharma
Teva won't say whether R&D cuts include layoffs; Cipla inks deal for Iranian plant; | Fierce Pharma

Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.

Teva China API plant smacked by FDA warning letter, adding to drugmaker's  burdens
Teva China API plant smacked by FDA warning letter, adding to drugmaker's burdens

DEF 14A
DEF 14A

Bank of New York Mellon Corp Increases Investment in Teva Pharmaceutical  Industries Despite Declining Revenue and FDA Warnings - Best Stocks
Bank of New York Mellon Corp Increases Investment in Teva Pharmaceutical Industries Despite Declining Revenue and FDA Warnings - Best Stocks

Teva Announces New Environmental, Social and Governance (ESG) Strategy and  Goals in 2020 Report | Business Wire
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report | Business Wire

TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.

EDGAR Filing Documents for 0001193125-23-106453
EDGAR Filing Documents for 0001193125-23-106453

TEVA - Teva Pharmaceutical Industries Limited - Depositary Receipt (Common  Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)
TEVA - Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)

TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.

Teva Pharmaceutical Industries Limited (TEVA) Market Cap (2013-2023) History
Teva Pharmaceutical Industries Limited (TEVA) Market Cap (2013-2023) History

Teva reaches $126M opioid settlement with hospitals - Top Class Actions
Teva reaches $126M opioid settlement with hospitals - Top Class Actions

DEF 14A
DEF 14A